{
  "data": {
    "indicator": {
      "slug": "change-in-regional-share-of-global-clinical-trial-country-uses",
      "name": "Change in regional share of global clinical trial country uses",
      "definition": "Percentage change in a region's share of global clinical trial country uses between two periods.",
      "unit": "percent",
      "scale": "1",
      "default_unit": "percent",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "percent",
    "region": {
      "code": "EU",
      "name": "European Union",
      "type": "bloc"
    },
    "points": [
      {
        "period_start": "2019-01-01",
        "period_label": "2019–2025",
        "value": -17,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_B0MJT3FDHN9S5XAPGB6GR93N6C",
        "url": "https://statorigin.org/stat/stat_B0MJT3FDHN9S5XAPGB6GR93N6C",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025",
          "locator": "Exhibit 55: Country utilization as percentage of global trial country uses, 2019 and 2025",
          "published_date": null
        }
      },
      {
        "period_start": "2019-01-01",
        "period_label": "2019–2025",
        "value": -17,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B",
        "url": "https://statorigin.org/stat/stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Global R&D Trends 2026",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026",
          "locator": "Exhibit 55: Country utilization as percentage of global trial country uses, 2019 and 2025",
          "published_date": null
        }
      },
      {
        "period_start": "2019-01-01",
        "period_label": "2019–2023",
        "value": 21,
        "scale": "1",
        "unit": "percent",
        "value_type": "actual",
        "statistic_id": "stat_1D4B4KPDFK0WHBM8D327B6EW89",
        "url": "https://statorigin.org/stat/stat_1D4B4KPDFK0WHBM8D327B6EW89",
        "source_org": "IQVIA",
        "source": {
          "org": "IQVIA Institute",
          "org_short_name": "IQVIA",
          "document_title": "Rethinking Clinical Trial Country Prioritization",
          "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization",
          "locator": "Key findings",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "EU",
      "NAMERICA",
      "CN"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 3
  }
}